Listen to this podcast with clinical and managed care pharmacy expert perspectives on the use of available and emerging subcutaneous immunotherapy options for patients with cancer.

An audio podcast with expert insights on what oncology pharmacists need to know to safely and effectively incorporate ADCs into solid tumor management.

Listen in as a respiratory diseases expert and radiology expert discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE.

Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss approaches to managing systemic mastocytosis—from earlier recognition and diagnosis to the use of emerging targeted therapies—that can reduce disease burden and improve outcomes for patients.

Listen to Allison Butts, PharmD, BCOP, review key highlights from a virtual live webinar on optimal approaches to ensure that comprehensive patient-centric care is provided for patients with HR+/HER2- metastatic breast cancer and various other comorbidities.

In this episode, Jessica Davis, PharmD, and Alexa Basilio, PharmD, explore the complexities of immune-related toxicities, offering expert insights on how to monitor, treat, and prevent these adverse events.

Listen as Su Wang, MD, MPH, FACP; Richard R. Andrews, MD, MPH; Ruth Brogden, MPH; and Amy S. Tang, MD, explore how early and sustained HBV care can be enhanced by expanding the role of primary care providers.

Listen as Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, review strategies for more expansive HBV treatment while considering adverse events, cost-effectiveness, and patient perspectives.

Listen as Douglas Dieterich, MD; Camilla S. Graham, MD, MPH; and Robert Wong, MD, MS, review barriers to and strategies for adopting new recommendations on universal HBV screening for all adults and best practices for screening of all patients with chronic HBV infection for HDV in the United States.

Hear Julie Ann Justo, PharmD, MS, FIDSA, BCPS, share her approach to treating CRE infections through a patient case, including a review of the changing epidemiology of CRE, contributing mechanisms of resistance, and current IDSA guidance recommendations based on the latest data.

Tune in to this podcast episode for expert pharmacist insights on proactively incorporating RSV vaccination strategies in your practice! Dr Christina Madison and Dr Mary Bridgeman provide practical guidance for educating patients, predicting and overcoming vaccination barriers, and the importance of shared decision-making.

Tune in to this podcast episode from Dr Christina Madison and Dr Mary Bridgeman to hear expert pharmacist insights on new and emerging RSV vaccines for older adults, including a review of the most recent clinical efficacy and safety data.

Tune in to this podcast from Dr Mary Bridgeman for expert pharmacist insights on the burden of RSV on older adults, including clinical manifestations, recognizing those most at risk, and protecting vulnerable patients.

Experts discuss their experiences with providing patient education on PARP inhibitors and mirvetuximab soravtansine and a potentially emerging treatment modality in advanced ovarian cancer.

Listen to Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss updated information regarding outpatient management of COVID-19, including testing, risk stratification, treatment guidelines, treatment selection, and long COVID.

In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; their benefits in heart failure; and their role in the updated consensus statement from the American Diabetes Association/European Association for the Study of Diabetes.

Drs Diana Isaacs and Joshua J. Neumiller summarize key information on the evidence behind the use of finerenone in diabetic kidney disease, selecting appropriate patients for finerenone therapy, and the role of the pharmacist in caring for these patients.

In this podcast, expert cardiology pharmacist Dr Kathleen Lusk provides insights on best practices for engaging patients and the healthcare team in collaborative, shared decision-making for management of NVAF.

In this podcast, expert cardiology pharmacists Dr Kathleen Lusk and Dr Stephanie Dwyer Kaluzna discuss the prevalence, burden, and consequences of undiagnosed NVAF. They will explore evidence-based methods for NVAF screening and provide strategies to incorporate these within various pharmacy settings.

In this podcast, expert cardiology pharmacist Dr Stephanie Dwyer Kaluzna discusses evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.